Condition

Myocardiopathies (2)

Arrythmia (1)

Death, Sudden, Cardiac (1)

Heart Decompensation (1)

Heart Failure, Congestive (1)

Ischemia, Myocardial (1)

Left Ventricular Failure (1)

Systolic or Diastolic Left Ventricular Dysfunction (1)

Overall Status

Completed (2)

Sign in for free

Phase

phase 2 (1)

Sponsor

Daiichi Sankyo, Inc. (1)

Thomas Jefferson University (1)

Collaborator

Medtronic (1)

Intervention

carperitide (1)

placebo (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (1)

Observational (1)

myocardiopathies

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

CHF, Heart Decompensation, Left Ventricular Failure Trial in Canada, United States (Carperitide, Placebo)

Completed

Heart Failure, Congestive
+4 more

Carperitide
Placebo

Huntsville, Alabama
+33 more

Nov 4, 2016

Extracellular Matrix Marker of Arrhythmia Risk (EMMA)

Completed

Myocardiopathies
+3 more

Philadelphia, Pennsylvania

Jefferson Heart Institute

May 5, 2014